SMJ // Prostate Disorders

SMJ Article | Original Article

Awareness and Indications of 5-α-Reductase Inhibitors for Benign Prostatic Hyperplasia in the Primary Care Setting

Objective: The objective of the study was to investigate primary care physicians’ (PCPs’) level of awareness and indications for urology referral in patients treated with 5-α-reductase inhibitors (5-ARIs). Methods: An anonymous 14-question survey was e-mailed to PCPs in the specialties of Family Medicine and Internal Medicine at an academic institution....

Posted in: Prostate Disorders3

SMJ Article | Review Article

Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease

Androgen deprivation therapy is the cornerstone of systemic management for prostate cancer but is associated with multiple adverse effects that must be considered during treatment. These effects occur because of the profound hypogonadism that is induced from lack of testosterone or due to the medications used in the treatment or...

Posted in: Prostate Disorders3

SMJ Article | Original Article

OPEN: Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer

Objectives: 18F-fluciclovine (fluciclovine) is an amino acid analog approved by the Food and Drug Administration for use as a radiotracer in positron emission tomography (PET) in men with biochemical recurrence of suspected prostate cancer. The purpose of this study was to investigate the initial institutional experience with 18F-fluciclovine in the...

Posted in: Nephrology and Urology14 Urologic Cancer1 Prostate Disorders3
SMA Menu